U.S. markets close in 3 hours 4 minutes
  • S&P 500

    4,316.20
    -93.93 (-2.13%)
     
  • Dow 30

    33,933.06
    -431.44 (-1.26%)
     
  • Nasdaq

    13,436.21
    -418.92 (-3.02%)
     
  • Russell 2000

    1,982.28
    -51.23 (-2.52%)
     
  • Crude Oil

    85.10
    +1.79 (+2.15%)
     
  • Gold

    1,849.60
    +7.90 (+0.43%)
     
  • Silver

    23.85
    +0.05 (+0.21%)
     
  • EUR/USD

    1.1289
    -0.0041 (-0.36%)
     
  • 10-Yr Bond

    1.7570
    +0.0220 (+1.27%)
     
  • GBP/USD

    1.3495
    +0.0004 (+0.03%)
     
  • USD/JPY

    113.8360
    -0.1240 (-0.11%)
     
  • BTC-USD

    37,231.80
    +1,812.50 (+5.12%)
     
  • CMC Crypto 200

    846.71
    +26.12 (+3.18%)
     
  • FTSE 100

    7,371.46
    +74.31 (+1.02%)
     
  • Nikkei 225

    27,131.34
    -457.03 (-1.66%)
     

Laboratory Corporation of America Holdings (NYSE:LH) Knows How To Allocate Capital Effectively

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • LH

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, the ROCE of Laboratory Corporation of America Holdings (NYSE:LH) looks great, so lets see what the trend can tell us.

Return On Capital Employed (ROCE): What is it?

For those that aren't sure what ROCE is, it measures the amount of pre-tax profits a company can generate from the capital employed in its business. To calculate this metric for Laboratory Corporation of America Holdings, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.25 = US$4.4b ÷ (US$20b - US$2.7b) (Based on the trailing twelve months to June 2021).

So, Laboratory Corporation of America Holdings has an ROCE of 25%. In absolute terms that's a great return and it's even better than the Healthcare industry average of 12%.

See our latest analysis for Laboratory Corporation of America Holdings

roce
roce

Above you can see how the current ROCE for Laboratory Corporation of America Holdings compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Laboratory Corporation of America Holdings.

How Are Returns Trending?

Laboratory Corporation of America Holdings is displaying some positive trends. Over the last five years, returns on capital employed have risen substantially to 25%. Basically the business is earning more per dollar of capital invested and in addition to that, 37% more capital is being employed now too. This can indicate that there's plenty of opportunities to invest capital internally and at ever higher rates, a combination that's common among multi-baggers.

The Bottom Line

A company that is growing its returns on capital and can consistently reinvest in itself is a highly sought after trait, and that's what Laboratory Corporation of America Holdings has. Since the stock has returned a staggering 126% to shareholders over the last five years, it looks like investors are recognizing these changes. In light of that, we think it's worth looking further into this stock because if Laboratory Corporation of America Holdings can keep these trends up, it could have a bright future ahead.

On a final note, we found 2 warning signs for Laboratory Corporation of America Holdings (1 can't be ignored) you should be aware of.

If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.